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Introduction
Premenstrual dysphoric disorder (PMDD), the most severe form of a menstrually related 
mood disorder (MRMD), afflicts 5-8% of women of reproductive age (Kroll & Rapkin, 
2006). The prevalence of clinically significant premenstrual symptoms that are characterized 
by impairment, treatment seeking, and suicide risk, but do not meet DSM-IV requirement 
for the presence of five different symptoms, raises the percentage of afflicted women to 13–
19% (Angst, Sellaro, Merikangas, & Endicott, 2001; Bunevicius, Leserman, & Girdler, 
2012; Spitzer, Williams, Kroenke, Hornyak, & McMurray, 2000). PMDD is characterized 
by the cyclic recurrence of affective and somatic symptoms in the luteal phase of the 
menstrual cycle, resulting in luteal phase impairment equivalent to that of major depression, 
panic disorder, and post-traumatic stress disorder (PTSD) (Kroll & Rapkin, 2006; Lystyk & 
Gerrish, 2006). The most frequent core symptoms of PMDD are irritability, anger conflict, 
and emotional lability, and as mindfulness has demonstrated effectiveness in addressing 
similar symptoms in previous research (Greeson, 2009), we rationalized that mindfulness 
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Despite the efficacy of SSRIs and a low-dose oral contraceptive in PMDD (Freeman et al., 
2001; Steiner et al., 2006; Yonkers et al., 2005), non-response rates are ≥ 40% (Freeman, 
Rickels, Sondheimer, & Polansky, 1999; Halbreich, 2008; Steiner et al.,1995) and nearly 
50% of MRMD women prescribed SSRIs do not take them or discontinue within six months 
(Sundstrom-Poromaa, 2000). Research on behavioral interventions in MRMD is sparse, with 
three randomized trials (Blake, Salkovskis, Gath, Day, & Garrod, 1998; Hunter et al., 2002; 
Morse, Dennerstein, Farrell, & Varnavides, 1991). These previous studies supported the 
efficacy of cognitive therapy as equivalent to fluoxetine, and superior to hormone therapy 
and relaxation, for alleviating PMDD symptoms; however these studies are more than ten 
years old, the behavioral interventions were not manualized or well described, and there was 
no attempt to investigate mechanisms of efficacy. Ideally, intervention approaches should 
both arise from an understanding of mechanisms and simultaneously inform about the 
pathophysiology of the disorder.
Women with a MRMD exhibit dysregulation in cardiovascular stress reactivity (Girdler, 
Pedersen, & Light, 1995; Girdler et al., 1998; Klatzkin, Lindgren, Forneris, & Girdler, 2010) 
and greater sensitivity to laboratory pain stimuli (Fillingim, 1995; Fleischman, Bunevicius, 
Leserman, & Girdler, 2013; Straneva et al., 2002) than controls. By extension, the 
theoretical framework driving the choice of mindfulness training as an intervention in 
MRMD is derived from the evidence for its ability to modulate stress, arousal and emotion 
regulation (Greeson, 2009), which are key challenges for women with PMDD. Mindfulness 
is defined as bringing one's awareness to moment-to-moment experiences without judgment 
(Kabat-Zinn, 1994). Mindfulness training decreases blood pressure (Nyklicek, 
Mommersteeg, Van Beugen, Ramakers, Van Boxtel, 2013; Hughes et al., 2013) and is 
efficacious in treating pain syndromes (Greeson, 2009; Reiner, Tibi, & Lipsitz, 2013). A 
consequence of mindfulness training is the realization that most thoughts and emotions 
fluctuate or are transient (Baer, 2003) and that these momentary experiences can be simply 
acknowledged as mental phenomena rather than reality, and allowed to pass. Such a 
perspective makes mindfulness training well suited to MRMD, since MRMD symptoms 
fluctuate with the hormones that drive them. The purpose of our pilot study was to assess 
recruitment, feasibility, adherence and potential mechanisms of efficacy associated with 
mindfulness training, and to support whether a randomized controlled trial (RCT) should be 
conducted in women with PMDD symptoms.
Method
Participants
After the University of North Carolina IRB approved the study, women were recruited 
through newspaper advertisements and flyers posted in the community; also, women were 
contacted who were originally enrolled in a prospective MRMD diagnostic study that served 
as a feeder study for other research studies (Bunevicius et al., 2012; Fleischman et al., 2013) 
and as a registry for future contact. Women were evaluated for medical and psychiatric 
histories using the MINI psychiatric interview (American Psychiatric Association & 
American Psychiatric Association Task Force on DSM-IV, 2000; Sheehan et al., 1998). All 
women were in good health, without chronic medical conditions or current psychiatric 
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disorders. Women were then prospectively evaluated for two to three menstrual cycles to 
determine MRMD status.
MRMD diagnosis—The Daily Record of Severity of Problems (DRSP) allows for the 
quantification of the severity of physical, emotional and behavioral symptoms using a 6-
point scale (Endicott, Nee, & Harrison, 2006). In order to discourage retrospective reporting, 
forms were mailed back weekly. Each woman met the following criteria: (1) at least a 30% 
decrease in emotional symptom severity between the seven luteal phase days preceding 
menses compared with follicular phase days 4–10; (2) a rating of emotional symptoms as 
moderate, severe or extreme on at least two of the seven premenstrual days; (3) remission of 
symptoms shortly after the onset of menses followed by a clear symptom-free period during 
the early-to-mid follicular phase and (4) criteria 1-3 met in at least two menstrual cycles 
(Endicott et al., 2006; Rubinow, Roy-Byrne, Hoban, Gold, & Post, 1984).
Twenty-eight women from the MRMD registry were invited to participate; 24 enrolled (80% 
recruitment rate), and 21 completed the MBSR class. Recent medical and psychiatric history 
were reviewed to determine if participants were still free of any current psychiatric disorder 
and chronic medical condition affecting eligibility. Additional eligibility required women to 
be 18-52 years of age with intact ovaries and not pregnant or nursing. After eligibility was 
established, the study was explained to women in detail by the study coordinator and women 
provided written consent. A brief, 11-item version of the DRSP form for PMDD symptoms 
was reviewed. Participants completed the daily ratings throughout the 12-week study period.
Data included in this manuscript are from two separate pilot studies (Pilot 1, n = 9; Pilot 2, n 
= 12). Procedures were identical in the two pilots except that two additional questionnaires 
were administered in the second pilot: the ruminative and reflection questionnaire (RRQ) 
and the self-compassion scale (SCS). Also, two different instructors taught the mindfulness 
intervention, both of whom were well trained and experienced in teaching the Mindfulness 
Based Stress Reduction (MBSR) curriculum as taught through the Center for Mindfulness at 
University of Massachusetts Medical Center.
Procedure
Daily Record of Severity of Problems (DRSP; Endicott et al., 2006)—Eleven 
items from this scale were used to evaluate the severity of core emotional (depression, 
hopelessness, worthlessness, anxiety, mood swings, sensitivity, irritability, conflict with 
others) and physical symptoms (sleeplessness, headache, and joint pain) of PMDD. The 
DRSP was completed daily and returned each week to the study coordinator.
Laboratory testing—All participants were tested during the first two weeks before 
starting the MBSR program (weeks 1 and 2) and within two weeks after completing the 
MBSR intervention (weeks 11 and 12). Testing involved: 1) Pain Testing; 2) 
Instrumentation for blood pressure (BP) and heart rate (HR); 3) Recovery and Pre-stress 
Baseline Rest; and 4) Trier Social Stress Test (TSST; Fig. 1).
Pain Testing Procedures: Participants were exposed to two pain tests with a five-minute 
recovery imposed between tests. The cold pressor test was presented first, followed by the 
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tourniquet procedure. Both tests have been shown to differentiate MRMD women from non-
MRMD controls (Fleischman et al., 2013).
The hand cold pressor: A container was filled with ice and water maintained at 4° C. At the 
onset of the test, participants submerged their hand to their wrist and kept their hand still. 
The use of a water circulator prevented the water from warming near the participant's hand. 
Participants indicated when the sensations in their hand first became painful (pain threshold) 
and when they were no longer willing or able to tolerate the pain (pain tolerance). 
Immediately before removing their hand, participants rated the pain for intensity and 
unpleasantness using a visual analogue scale (0 – 100). A maximum time limit of five 
minutes was imposed though participants were not informed of this limit.
The submaximal effort tourniquet procedure: The participant's arm was raised for 30 
seconds to promote venous drainage and then the tourniquet cuff positioned on the arm was 
rapidly inflated to 200 mmHg (via the Hokanson E20 Rapid Cuff Inflator) and the arm 
returned to the participant's side. To promote forearm ischemia, participants engaged in 20 
handgrip exercises at 30% of maximum force with an inter-squeeze interval of two seconds. 
Participants verbally indicated when the sensations in their arm first become painful (pain 
threshold) and when they are no longer willing or able to tolerate the task (pain tolerance). 
Before deflating the cuff, participants rated both the intensity and the unpleasantness of the 
pain using the visual analogue scale. A maximum time limit of 20 minutes was imposed 
though participants were not informed of this limit.
Recovery and baseline rest: Participants sat quietly alone in a comfortable chair for 15 
minutes. The first 10 minutes served as recovery from pain testing, while the last five 
minutes constituted the baseline from which to calculate cardiovascular reactivity to the 
stress test. BP and HR were taken at minutes 11, 13, and 15 and averaged.
The Trier social stress test (TSST; Kirschbaum, Pirke, & Hellhammer, 1993): This is a 
well validated test that induces large BP and HR responses (Kirschbaum, Strasburger, & 
Langkrar, 1993; von Kanel, Kudielkac, Preckelb, Hanebuthb, & Fischerb, 2006) and 
involves the following components:
Pre-task instructions.: Participants were introduced to one or two people (the ‘selection 
committee’) after which the experimenter asked the participant to take over the role of a job 
applicant who was invited for a personnel interview with the company's staff managers (the 
selection committee). Participants were instructed that they would be tape-recorded and 
video-recorded and that the managers were trained to monitor nonverbal behavior.
Anticipation: The participant prepared her talk for five minutes in the presence of the 
committee. During this time, she was permitted to take notes.
Speech: The committee asked the participant to deliver her talk for five minutes. If the 
participant finished her talk before five minutes, the committee responded with prepared 
questions to ensure that the participant spoke for the entire time.
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Serial subtraction: The committee then asked the participant to subtract the number seven 
from 2,000 as fast and as accurately as possible for five minutes. For each mistake, the 
participant was instructed to restart at 2,000.
BP and HR were taken at minutes 0, 2, 4, 6, and 9 during the baseline period, and at minutes 
0, 2, and 4 during the anticipation, speech, and subtraction phases of the TSST. The values 
within each period were then averaged to establish a mean blood pressure and heart-rate 
value for each period. The Suntech Exercise BP monitor, Model 4240 (SunTech Medical 
Instruments, Inc., Raleigh, NC) was used to provide automated measurement of BP and HR. 
The Suntech Exercise BP monitor uses the auscultatory technique, with R-wave Gating, and 
is accurate within ±2 mmHg between 0 mmHg and 300 mmHg. Prior to initiating the initial 
rest period, three standard stethoscopic blood pressures were taken with the automated 
pressures in order to ensure correct microphone placement and cuff positioning.
Mindfulness based stress reduction (MBSR)—This program, developed by Jon 
Kabat-Zinn at the University of Massachusetts Medical Center, was implemented with 
minimal adaptation. It was conducted in a small group setting and delivered by trained 
MBSR instructors from the UNC Program on Integrative Medicine. The intervention 
included two-hour sessions for eight consecutive weeks plus a Saturday retreat near the end 
of the intervention. The Saturday retreat was modified from six hours to four hours.
Class 1: Introduction to the body scan, a practice to facilitate non-judgmental awareness 
of physical sensations, and an eating meditation that focused on differentiating physical 
sensations from thoughts.
Class 2: Introduction to sitting meditation with awareness of breathing as the primary 
object of attention.
Class 3: Introduction to gentle mindful yoga movements as a way of bringing awareness 
to subtle movements of the body.
Class 4: Introduction of walking meditation; the psychophysiology of the stress 
response was discussed.
Class 5: Sitting meditation was expanded to include awareness of thoughts arising and 
passing away, and discussion included the role of mindfulness in responding to stress in 
everyday life.
Class 6: Working with strong emotions was discussed as well as expanding the inner 
resources for emotional resilience.
Saturday Half-Day Retreat: Introduction to the concept of “functional silence”. 
Participants engaged in staff-led sitting meditation sessions, alternating with walking 
meditation, mindful yoga, and the body scan. Lunch was held in silence. In the afternoon, 
there was an introduction to loving-kindness meditation. Discussion at the end of the day 
allowed participants to share their experiences, challenges, and insights.
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Class 7: Introduction to ‘choiceless awareness’ (a practice in which one is fully aware of the 
moment, yet not focused on any physical or mental image or object); awareness of how we 
nourish our bodies.
Class 8: A review of the course and cultivating resources for continued practice was 
discussed.
Measures
All questionnaires were completed both before and after the eight-week MBSR intervention.
Outcome Measures
Daily Record of Severity of Problems (DRSP; Endicott et al., 2006): Eleven items from 
this scale were used to evaluate the severity of core emotional (depression, hopelessness, 
worthlessness, anxiety, mood swings, sensitivity, irritability, conflict with others) and 
physical symptoms (sleeplessness, headache, and joint pain) of PMDD.
Pain Sensitivity: For both the hand cold pressor (Mitchell, Macdonald, & Brodie, 2004) and 
submaximal effort tourniquet procedures (Moore, Duncan, Scott, Gregg, & Ghia, 1979), 
measures of pain threshold, tolerance, intensity and unpleasantness were assessed. 
Participants informed the task administrator when the onset of pain first occurred (threshold) 
and when pain could no longer be tolerated (tolerance), and number of seconds for each was 
noted. At the end of each task, participants rated pain on a visual analogue scale (0 being 
“no pain”, and 100 being “the worst pain imaginable”) for both pain intensity (the strength 
of the pain) and pain unpleasantness (the degree to which the pain was bothersome). 
Reliability and validity of both pain measures has been established (Edens & Gil, 1995).
Potential Mediators—Pain catastrophizing scale (PCS; Sullivan, Bishop, & Pivik, 1995) 
evaluates participants’ relationship to their pain. This scale assesses thoughts and feelings 
associated with pain in three domains: ruminating, magnifying, and hopelessness. Construct 
validity and temporal stability have been established (Sullivan, Bishop & Pivik, 1995).
Rumination and reflection questionnaire (RRQ; Trapnell & Campbell, 1999) differentiates 
between the rumination (anxious self-focus) and reflection (inquisitiveness self-focus) facets 
of private self-consciousness. The rumination and reflection subscales each contain 12 items 
and responses are given on a 5-point Likert scale. A Cronbach's alpha of .90 has been 
reported for the rumination subscale and .91 for the reflection subscale. Discriminant and 
concurrent validity have been established through comparisons with related scales (Trapnell 
& Campbell, 1999).
Five Facet Mindfulness Questionnaire (FFMQ; Baer, Smith, Hopkins, Krietemeyer, & 
Toney, 2006) is a 39-item scale that measures the construct of mindfulness. Five facets 
compose the constructs: observing, describing, acting with awareness, non-judging of inner 
experience, and non-reactivity to inner experience. Items were rated on a 5-point scale 
ranging from 1 (never or very rarely true) to 5 (very often or always true). Higher scale 
scores indicate higher overall mindfulness. The five factors demonstrate good internal 
consistency with Cronbach alphas ranging from .72 - .92 (Baer et al., 2008; Christopher, 
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Neuser, & Baitmangalkar, 2012), and construct validity has been established (Baer et al, 
2008).
Self-compassion Scale (SCS; Neff, 2003) is a 26-item scale that measures self-compassion, 
defined as “holding one's feelings of suffering with a sense of warmth, connection, and 
concern” (Neff & McGehee, 2010, p. 226). This scale comprises the three facets of self-
compassion measured as six subscales: mindfulness vs. over-identification, self-kindness vs. 
self-judgment, and common humanity vs. isolation. Internal consistency for this scale is 
excellent (Cronbach's alpha = .93; Neff, 2003) and construct validity has been established 
through positive associations with the Social Connectedness scale and three subscales of the 
Trait-Meta Mood Scale, and negative associations with the self-criticism subscale of the 
Depression Experience Questionnaire (Neff, 2003).
Beck Depression Inventory (BDI; Beck & Beamesdefer, 1974) is a widely used well-
validated 21-item self-report measure that assesses depressive symptoms. A meta-analysis of 
internal consistency of this scale reported a reliability of .81 for non-psychiatric patients. 
Concurrent validity for non-psychiatric individuals with the Hamilton Psychiatric Rating 
Scale for Depression and clinical ratings were good; correlations with these measures were .
74 and .60, respectively (Beck, Steer, & Carbin, 1988).
Spielberger State Anxiety Inventory (STAI; Spielberger, Gorsuch, & Lushene, 1970) is a 
widely used 20-item self-report scale in which respondents rate their current levels of 
anxiety on a 4-point Likert scale, ranging from 1 (not at all) to 4 (very much so). Reported 
reliabilities range from .65 to.96 (Barnes, Harp, & Jung, 2002).
Process Evaluations—Stress Reduction Questionnaire was used at the end of the second 
laboratory session to evaluate whether participants used any stress reduction skills during 
the laboratory protocol. This five-item questionnaire created for this study asked questions 
such as: What stress reduction skills, if any, did you use during today's session? and Did you 
use these skills when you felt pain? If yes, to what extent did they help you to tolerate pain?
MBSR questionnaire was created for this study and administered during the last MBSR 
session to evaluate experiences during the MBSR program. On a Likert scale ranging from 
1(not at all) to 5 (very much), participants were asked to respond to eight questions. 
Examples of these questions include: To what extent has participation in this course 
impacted your ability to manage your stress and PMDD symptoms? and To what extent 
have you made changes in your daily activities as a result of this course?
Compliance Measure—MBSR diary assessed the daily recorded number of minutes spent 
with each MBSR practice each day at home. Participants were also asked to indicate the 
amount of time spent on each type of activity (i.e., mindful breathing, yoga, loving-kindness 
meditation). These diaries were returned weekly to the study coordinator at each MBSR 
class session.
Historical Control Comparison Groups: Sixty-one women who had entered the MRMD 
diagnostic feeder study described above and met MRMD criteria were used as historical 
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control groups. For a different protocol (Bunevicius et al., 2013; Klatzkin, Bunevicius, 
Forneris, & Girdler, 2014), these women had completed daily mood ratings using the DRSP 
over several months and 39 of the women had undergone pain testing with both pain tests on 
two occasions approximately eight weeks apart. However, these women had no intervention 
over the course of their participation. The 61 women provided a control for repeated 
symptom monitoring and the 39 woman subgroup served as the control for habituation to 
repeated pain testing. No significant differences existed between the MBSR group and the 
control group in age, minority distribution, or psychiatric histories (Table 1).
Data Analyses
Mean luteal phase symptom severity derived from the DRSP instrument completed during 
the diagnostic study served as the baseline comparison from which to assess MBSR-related 
change. Paired t-tests were conducted for each of the 11 symptoms to assess change from 
pre to post MBSR. For the control group, DRSP measures for the same symptoms were 
assessed over an 8–12 week rating period. For each symptom, change scores were created 
(mean luteal phase severity level at the end of the ratings period – mean luteal phase severity 
level at the beginning of the rating period) and independent t-tests were conducted to assess 
group differences in the change in symptom severity over time.
For each pain measure (threshold, tolerance, intensity, unpleasantness), change scores were 
created (mean post intervention level – mean pre intervention level) and analyzed using 
independent t-tests. Similarly for the control group, change scores were created for each 
measure (mean week 8 pain level minus mean week 1 level) and independent t-tests were 
conducted to assess group differences in pain sensitivity over time.
For SBP, DBP, and HR, cardiovascular reactivity stress scores were created separately for 
the pre-intervention and post-intervention sessions (mean stressor level – mean baseline rest 
level). Then, pre- versus post-intervention differences in reactivity were analyzed separately 
for each cardiovascular measure and each stressor condition (anticipation, speech, and math) 
using paired t-tests.
Potential mediators (BDI, STAI, PCS, RRQ, SCS, FFMQ) were analyzed using paired t-
tests. All analyses were conducted using SPSS 20.
Results
Twenty-eight participants were initially recruited for the study. Two withdrew prior to 
enrollment (one due to travel distance from the study, one due to an Axis 1 psychiatric 
diagnosis), two withdrew after enrollment but prior to the start of the intervention (one due 
to busy schedule, one for unknown reason), and three withdrew after week two of the 
intervention (one due to new job, one due to illness, and one due to heightened anxiety). 
Therefore, of those who began the mindfulness classes, 88% (n = 21) completed the classes 
and all post-intervention measures. The intervention covered eight classes (or 49 days, 
including the first and last class). Overall, participants engaged in some type of mindfulness 
practice at home 80% of the days, for a mean of 131 minutes per week.
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In relation to the DRSP, there was a significant decrease from pre- to post-MBSR training in 
premenstrual ratings of depression (t(19) = 3.27, p =.004), hopelessness (t(19) = 2.43, p =.
025), anxiety (t(19) = 3.66, p =.002), mood swings (t(19) = 7.60, p < .001), sensitivity (t(19) 
= 3.39, p =.003), irritability (t(19) = 4.92, p < .001), and conflict with others (t(19) = 4.82, p 
< .001). The magnitude of symptom severity in worthlessness (t(19) = 1.70, ns), 
sleeplessness (t(19) = 1.42, ns), headache (t(19) = 1.61, ns), and joint pain (t(19) = 0.35, ns) 
did not decrease significantly. For the control group, no change was observed in any of the 
11 symptom ratings over the eight-week period. Consequently, there was a significant 
difference in change scores between the two groups in depression (t(79) = 3.75, p < .001), 
hopelessness (t(79) = 3.02, p = .003), anxiety (t(79) = 2.88, p = .005), mood swings (t(79) = 
4.53, p < .001), sensitivity (t(79) = 4.07, p < .001), irritability (t(79) = 3.76, p < .001), 
conflict with others (t(79) = 4.11, p < .001), and worthlessness (t(24) = 2.45, p = .017). 
There was no difference between the groups in change scores in sleep problems (t(79) = .95, 
ns) headaches (t(79) = .84, ns), and joint pain (t(25) = 0.36, ns) (see Table 2, Fig. 2).
An increase in pain tolerance to the cold pressor task was observed from pre to post MBSR 
intervention (t (20) = −2.46, p = .02), which was significantly different from that of the 
control group (t (58) = −2.53, p = .02), for whom no change in cold pressor tolerance 
occurred over eight weeks (Fig. 3). No significant effects emerged for cold pressor pain 
threshold (t (20) = −1.64, ns), intensity (t (20) = −.98, ns) or unpleasantness ratings (t (20) = 
−1.70, ns) (Table 2). There were no significant effects for the submaximal effort tourniquet 
test.
Significant decreases were observed from pre to post intervention in the anticipation phase 
of the TSST for systolic BP and HR reactivity (t(20) = 2.16, p = .04 and t(20) = 2.71, p = .
01, respectively) and a trend for reduced diastolic BP reactivity (t(20) = 1.90, p = .07). There 
was also a trend for reduced heart rate reactivity from pre to post intervention during the 
speech (t(20) = 1.90, p = .07) (Table 3).
Reductions from pre to post MBSR were observed in ruminating on pain (t (19) = 2.43, p = .
03) and magnifying pain (t (19) = 2.40, p = .03), while the global pain score only tended to 
decrease (t (19) = 1.95, p = .07). There was also no change in either the rumination or 
reflection subscale of the RRQ from pre to post MBSR: (t(10) = 1.34, p = ns; t (10) = −.76, p 
= ns; respectively). An increase from pre- to post-MBSR was observed in the subscales self-
kindness (t (10) = −3.22, p = .009) and common humanity (t (10) = −3.20, p = .009) of the 
SCS, although there were no changes in self-judgment, isolation, mindfulness or over-
identification. There was an increase from pre to post MBSR in the FFMQ facets of 
observing (t (19) = −2.77, p = .01), acting with awareness (t (19) = −2.28, p = .03), and non-
judging inner-experience (t (19) = −3.93, p = .001), though not with describing and non-
reacting to inner experience. There was no change in depression from pre to post MBSR (t 
(11) = .765, p = ns).There was also no change in either state or trait anxiety from pre to post 
(state: t(18) = −.592, p = ns); trait: t(19) = .122, p = ns) (Table 3).
Participants shared positive reflections on their experience of the MBSR course. Although 
one participant indicated her tentativeness with the practice, “[The course] was overall a 
good experience. I am unsure of my ability to relax and meditate”, the other participants felt 
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the course had a profound impact on the way in which they experienced their lives, stating 
that it was “eye-opening” and that “It changed my life” and “[It gave me] ...tools to help 
manage my emotions and stress when I feel out of control; I can have control.”
All women indicated that they used one or more tools that they had learned in the MBSR 
course while undergoing the post stress and pain testing procedures. Ninety-five percent (n = 
20) used a breathing technique, 62% (n = 13) used a body scan, 20% (n = 4) used observing 
physical sensations, 14% (n = 3) used noticing thoughts and letting them go or loving-
kindness, and 5% (n = 1) employed visualization or stretching.
Discussion
The results of this pilot suggest that the standard MBSR course is acceptable, well-tolerated 
and potentially beneficial in women with a MRMD. Eighty-eight percent of the women who 
began the intervention completed not only the full program but also all post-intervention 
laboratory assessments. This rate is consistent with other reports of participants with mood 
disorders in MBSR classes (Lee et al., 2007; Ma & Teasdale, 2004; Vollestad, Sivertsen, & 
Nielsen, 2011). Similarly, self-reported rates of daily mindfulness practice were on par with 
other reports (Vettese, Toneatto, Stea, Nguyen, & Wang, 2009). The process measures 
obtained support the retention and compliance data in that the majority of women were 
employing one or more of the mindfulness-based techniques to reduce their stress in the 
laboratory. Additionally, data from the MBSR diary support that the women were also 
applying these skills in their lives.
Although the self-report nature of the home-practice data may be viewed as a limitation, it is 
corroborated by the primary outcome data. There were clinically and statistically significant 
reductions in seven premenstrual emotional symptoms following MBSR training, and these 
reductions were significantly greater than changes seen in the historical control group, for 
which there was no change in symptom severity with daily ratings alone. The efficacy of 
MBSR to have beneficial effects on mood symptoms in controlled trials has been previously 
demonstrated (Greeson, 2009; Khoury et al., 2013), but this is the first demonstration that it 
may be efficacious for premenstrual symptoms using daily prospective ratings in a 
population who suffer from a MRMD.
In contrast, there was no evidence for improvement with MBSR in feelings of 
worthlessness, sleep, headache pain or joint pain severity. Lack of significant change in 
feelings of worthlessness is unexpected, given the finding of significant decrease in a similar 
variable, hopelessness; however, there were trends towards a decrease in sense of 
worthlessness. Small sample size and reduced statistical power may have contributed to the 
absence of an effect. Findings for lack of significant change in sleep, headache pain or joint 
pain severity are consistent with other literature showing greater MBSR-related 
improvements in psychological compared with physical domains of function (Khoury et al., 
2013). In this case, the small sample size and reduced statistical power may have contributed 
to the absence of an effect for these measures, at least for sleep and headache.
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Nonetheless, it was surprising that no effect of MBSR was seen for either headache or joint 
pain when MBSR was associated with significant reductions in pain sensitivity to the cold 
pressor test. The increase in cold pain tolerance was unlikely related to habituation since no 
effect of repeat testing on cold pain sensitivity was seen in the control group. Moreover, 
MBSR was not associated with a decrease in pain sensitivity to the tourniquet forearm 
ischemic pain test, suggesting that the ability of MBSR to beneficially modify pain 
sensitivity may depend, in part, on the pain modality. Indeed, three studies which utilized 
brief mindfulness interventions (Feuille & Pargament, 2013; Kingston, Chadwick, Meron, & 
Skinner, 2007; Liu, Wang, Chang, Chen, & Si, 2013) have reported that mindfulness 
practice decreases sensitivity to the cold pressor pain test. Evidence suggests that sensitivity 
to tourniquet-induced ischemic pain may involve endogenous opioid mechanisms (Frid, 
Singer, Oei, & Rana, 1981; Frid, Singer, & Rana, 1979), whereas sensitivity to cold pressor 
pain may be mediated by adrenergic mechanisms (Girdler et al., 2005). Thus, the possibility 
exists that different endogenous pain regulatory mechanisms may be differentially 
modulated by the MBSR intervention.
A number of controlled studies have reported that MBSR is associated with reductions in 
blood pressure responses to stress (Chen, Yang, Wang, & Zhang, 2013; Kingston et al., 
2007; Nyklicek et al., 2013; Parswani, Sharma, & Iyengar, 2013), consistent with MBSR 
modulation of adrenergic physiology (e.g., blood pressure). This study also found that 
MBSR was associated with statistically significant reductions in heart rate and systolic 
blood pressure stress reactivity. Although the results are limited by the absence of a control 
group for habituation of cardiovascular reactivity, other studies with the Trier Social Stress 
Test show that although habituation is evident, stress reactivity continues to be significant 
even when the test occurs over five consecutive days (Kirschbaum, Pirke, & Hellhammer, 
1993).
In addition to any MBSR-related reductions in cardiovascular stress reactivity that may 
serve as a potential mediator to the observed beneficial changes in symptoms and cold pain 
sensitivity, we also identified other potential mediators in this population to be tested in 
subsequent research. These include the mindfulness characteristics of observing, acting with 
awareness and non-judging inner-experiences; the self-kindness and common humanity 
components of self-compassion; and pain rumination and magnification. Of interest, there 
was no evidence in this cohort that general rumination changed with MBSR, nor did 
depressive or anxious symptoms unrelated to the menstrual cycle.
Conclusion
This pilot study supports testing the efficacy of the standard MBSR program for women 
with a MRMD in a controlled trial. Should it prove to be efficacious, investigating other 
interventions which incorporate mindfulness as a component, such as Mindful Self-
Compassion, is warranted. These would provide alternative viable behavioral interventions 
for a disorder for which current available treatment options are limited. Although this study 
suffers from the usual limitations inherent in pilot research, such as a small sample size and 
lack of an active control comparator group, the feasibility and adherence data are 
encouraging and the availability of the historical control groups for symptom and laboratory 
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pain measures reported herein strengthens the reliability of the primary outcome findings. 
Moreover, this study identified potential mediators of MBSR-related improvement. Future 
studies of biological and psychological mediators of MBSR-related benefit, not only in 
women with a MRMD but in other patient populations, would advance our understanding of 
mechanisms by which MBSR ameliorates psychological and medical suffering as well as 
further our understanding of the pathophysiology of stress-related disorders.
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Table 1
Demographics of Sample
Mindfulness (n=21) Historical Control for DRSP (n=61) Historical Control for Pain Measures (n = 39)
Mean Age 38 34 35
Race/Ethnicity (%)
    Caucasian 74 67 67
    African American 22 23 23
    Hispanic 4 5 5
    Asian 0 3 3
    Native American 0 2 3
% Depression 52 41 44
% Anxiety 10 8 8
% PTSD 10 10 8
% Alcohol abuse 7 11 10
% Substance abuse 0 8 10
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Table 2
Means and (SD) for Daily Symptom Ratings for MRMD Women Pre and Post MBSR Training
Daily MRMD Symptoms
MBSR Intervention (n = 21) Control (n = 61 for Daily Symptoms; n = 39 for Pain Symptoms)
Pre Post Pre Post
depression
** 3.31 (1.14) 2.47 (1.24) 2.62 (1.00) 2.84 (1.08)
hopelessness
* 2.28 (1.32) 1.74 (1.06) 2.06 (1.01) 2.21 (1.14)
worthlessness 2.39 (1.40) 1.81 (1.22) 2.13 (1.07) 2.26 (1.31)
anxiety
** 3.80 (1.17) 2.79 (1.14) 3.08 (1.10) 3.16 (1.04)
mood swings
** 3.85 (1.13) 2.39 (1.05) 3.04 (1.11) 3.01 (1.05)
sensitivity
** 3.41 (1.30) 2.20 (1.21) 2.85 (1.10) 2.94 (1.14)
irritability
** 4.03 (1.00) 2.57 (1.18) 3.30 (0.97) 3.26 (.95)
conflict with others
** 3.47 (1.01) 1.94 (0.97) 2.76 (1.14) 2.67 (1.08)
sleeplessness 2.70 (1.41) 2.21 (0.98) 2.57 (1.22) 2.41 (1.27)
headache 1.96 (1.12) 1.54 (1.07) 1.97 (1.00) 1.97 (1.04)
joint pain 2.54 (1.32) 2.42 (1.54) 2.21 (1.12) 2.24 (1.20)
Pain Sensitivity
Cold pressor
    threshold 14.10 (8.34) 35.76 (63.29) 24.49 (47.00) 21.49 (46.90)
    tolerance
* 68.14 (98.15) 111.52 (120.08) 75.08 (98.01) 67.05 (102.47)
    intensity 45.24 (16.24) 48.48 (20.22) 54.95 (21.28) 57.54 (23.60)
    unpleasantness 42.62 (20.35) 50.00 (21.97) 54.74 (23.60) 61.18 (25.53)
Tourniquet
    threshold 256.29 (286.77) 293.76 (294.29) 248.72 (273.31) 187.17 (204.92)
    tolerance 512.10 (384.25) 637.43 (407.50) 480.03 (318.51) 403.84 (351.25)
    intensity 40.25 (16.82) 37.71 (22.94) 40.26 (20.61) 41.28 (18.13)
    unpleasantness 34.95 (24.00) 43.57 (22.20) 40.64 (17.63) 46.36 (23.50)
*
indicates significant difference in intervention group at the .05 level (2-tailed) pre to post in the MBSR group,
**
indicates significance pre to post at the .01 level. There were no significant pre-post differences in the control group.
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Table 3
Mean and (SD) for Potential Mediators and Laboratory Stress data (n = 21)
Pre Post
TRIER
Preparation (mean - baseline)
    Heart rate* 13.68 (11.04) 8.24 (5.83)
    Systolic BP* 10.76 (10.04) 6.06 (6.00)
    Diastolic BP 6.94 (6.33) 3.98 (5.73)
Speech (mean - baseline)
    Heart rate 15.41 (9.52) 12.51 (8.31)
    Systolic BP 17.95 (8.46) 15.79 (7.04)
    Diastolic BP 11.93 (5.58) 11.04 (5.86)
Math (mean - baseline)
    Heart rate 10.26 (9.17) 9.12 (7.35)
    Systolic BP 11.37 (7.12) 11.35 (6.55)
    Diastolic BP 10.44 (4.96) 8.37 (5.67)
Pain Catastrophizing Scale
    Global 12.70 (9.49) 8.20 (10.38)
    Rumination* 5.80 (4.25) 3.40 (4.01)
    Magnification* 2.60 (2.39) 1.50 (2.04)
Rumination and Reflection Questionnaire
    Rumination 16.64 (6.62) 18.89 (4.56)
    Reflection 13.85 (5.97) 14.27 (3.75)
Self-compassion Scale
    Self-kindness** 2.71 (.87) 3.35 (.95)
    Self-judgment 3.16 (1.00) 2.97 (1.09)
    Common humanity** 3.43 (.81) 3.95 (.81)
    Isolation 2.93 (1.07) 2.80 (1.11)
    Mindfulness 3.30 (.59) 3.50 (1.08)
    Overidentification 3.23 (1.03) 3.02 (1.03)
Five facet Mindfulness Questionnaire
    Observing* 27.20 (4.32) 30.45 (4.55)
    Describing 29.35 (7.15) 29.65 (7.46)
    Acting with Awareness* 22.40 (5.93) 24.90 (7.77)
    Nonjudging** 23.90 (6.77) 29.30 (7.95)
    Nonreacting 19.30 (5.54) 21.60 (6.36)
Beck Depression Inventory 8.08 (5.11) 6.58 (6.63)
Spielberger State Anxiety Scale 44.53 (4.17) 45.05 (3.89)
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Pre Post
Spielberger Trait Anxiety Scale 47.30 (4.27) 47.20 (4.53)
*
indicates significance at the .05 level (2-tailed),
**
indicates significance at the .01 level (2-tailed)
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